Clinico-laboratory evaluation of the effectiveness of the new aminoglycoside antibiotic brulamycin (tobramycin) in treating surgical infections
Blatun, L.A.; Vandiaev, G.K.; Vishnevskiĭ, V.A.; Khlebnikov, E.P.; Makarenkova, R.V.
Antibiotiki 29(3): 228-232
1984
ISSN/ISBN: 0003-5637 PMID: 6732211 Document Number: 224191
The clinico-laboratory estimation of brulamycin in the treatment of 50 patients with severe wound infections showed its high efficacy with respect to gram-negative microflora and in particular Ps. aeruginosa (94 per cent of the sensitive strains). Satisfactory into the affection foci and a long-term maintenance of its therapeutic levels in the host allowed one to recommend the antibiotic for the treatment of patients with complicated purulent affections and first of all systemic infections.